Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Researchers use ATX-Red AR-2 as new imaging agent to illuminate tumors

Researchers from Echelon Biosciences, Inc. and collaborators from the University of Utah report the use of ATX-Red AR-2 as a new imaging agent that effectively illuminates tumors.

17 Dec 2013

Researchers discover direct evidence of genetic overlap between cognitive ability and schizophrenia

Investigators at The Feinstein Institute for Medical Research have discovered for the first time, direct evidence of a genetic overlap between schizophrenia and general cognitive ability. The findings are published online in Molecular Psychiatry.

17 Dec 2013

European team experts to explore role of neighborhood in everyday lives of people with dementia

A European team of experts led by The University of Manchester will explore, investigate and evaluate the role of the neighbourhood in the everyday lives of people with dementia and their families in a new research project announced during the G8 dementia summit today (11 December).

17 Dec 2013

New regulations could improve vets' access to care for some traumatic brain injuries

The Department of Veterans Affairs has approved new regulations to make it easier for veterans to receive health care and compensation for certain illnesses, including Parkinsonism, dementia, and depression, which have been linked to traumatic brain injury

17 Dec 2013

Research findings point to possible new strategy for treating ALS

Amyotrophic lateral sclerosis, better known as Lou Gehrig's disease, is a devastating illness that gradually robs sufferers of muscle strength and eventually causes a lethal, full-body paralysis. The only drug available to treat the disease extends life spans by a meager three months on average.

17 Dec 2013

New study aims to better understand brain aging and AD in adults with Down syndrome

To many, Down syndrome is a childhood condition. But improved health care means that individuals with DS now routinely reach age 50 or 60 years of age, sometimes beyond. However, if they live long enough, people with Down syndrome are almost certain to develop Alzheimer's disease.

17 Dec 2013

Targacept reports top-line results from TC-5619 Phase 2b trial for negative symptoms in schizophrenia

Targacept, Inc., a clinical-stage biopharmaceutical company developing novel NNR Therapeutics, today announced top-line results from a Phase 2b clinical trial of TC-5619 as an augmentation therapy for the treatment of negative symptoms of schizophrenia.

17 Dec 2013

Researchers identify first biomarker that appears to be associated with duration of delirium

Researchers from the Regenstrief Institute and the Indiana University Center for Aging Research have identified the first biomarker that appears to be linked to the duration of delirium.

16 Dec 2013

Researchers receive $6M grant to determine neuropathological condition of head injuries in non-athletes

Icahn School of Medicine at Mount Sinai researchers have been awarded a major federal grant to determine the long-term clinical and neuropathological sequelae of single and repeated head injuries in non-athletes.

16 Dec 2013

New Memorandum of Understanding signed to create partnership in neuroscience research

Today, Congressmen Steve Israel (D-NY) and Chaka Fattah (D-PA) announced the signing of a Memorandum of Understanding dedicated to creating a partnership in neuroscience research, and in particular, research on Alzheimer's disease.

16 Dec 2013

‘Window for intervention’ to forestall hypertensive cognitive decline

Newly diagnosed hypertension is predictive of cognitive decline in middle-aged individuals and is worse in those with poorly controlled blood pressure, Dutch researchers have found.

16 Dec 2013

First Edition: December 16, 2013

Today's headlines include findings from an Associated Press poll probing Americans thoughts about the health law.

16 Dec 2013

Two UTHealth professors elected fellows of American Association for the Advancement of Science

Two professors at The University of Texas Health Science Center at Houston - Barry Davis, M.D., Ph.D., and Kevin Morano, Ph.D. - have been elected fellows into the American Association for the Advancement of Science, the world's largest general scientific society and publisher of the journal Science.

16 Dec 2013

NIH publishes new informational booklet on Lewy body dementias

A new informational booklet on Lewy body dementias has been published by the National Institutes of Health for people living with LBD, their families and healthcare providers. The booklet was a collaboration among the Lewy Body Dementia Association, the Shiley-Marcos Alzheimer's Disease Research Center at the University of California, San Diego, the National Institute on Aging and National Institute of Neurological Disorders and Stroke.

14 Dec 2013

Study: Brain blood vessel cells may be therapeutic targets for Alzheimer's disease

A study in mice shows how a breakdown of the brain's blood vessels may amplify or cause problems associated with Alzheimer's disease. The results published in Nature Communications suggest that blood vessel cells called pericytes may provide novel targets for treatments and diagnoses.

14 Dec 2013

Standardized research approaches needed for developing new treatments for neurofibromatosis

As potentially effective new treatments for neurofibromatosis (NF) are developed, standardized research approaches—including outcome measures specific to NF—are needed. The first report from the Response Evaluation in Neurofibromatosis and Schwannomatosis (REiNS) International Collaboration has been published as a supplement to Neurology, the Official Journal of the American Academy of Neurology (AAN).

13 Dec 2013

Researchers uncover second rare genetic mutation linked to higher risk of Alzheimer's disease

A research team from The University of Nottingham has helped uncover a second rare genetic mutation which strongly increases the risk of Alzheimer's disease in later life.

13 Dec 2013

Lund University researcher explores why type 2 diabetes raises dementia risk later in life

It is well known that type 2 diabetes raises the risk of dementia. The reasons for this are less clear, but one explanation could be insulin resistance in the brain, according to Malin Wennstr-m, a researcher at Lund University's Molecular Memory Research Unit. She has received EUR 700,000 from the Swedish Research Council to investigate her theory.

12 Dec 2013

Blows to head may affect the brain's white matter and cognition even without concussion

New research suggests that even in the absence of a concussion, blows to the head during a single season of football or ice hockey may affect the brain's white matter and cognition, or memory and thinking abilities. The study is published in the December 11, 2013, online issue of Neurology, the medical journal of the American Academy of Neurology. White matter is brain tissue that plays an important role in the speed of nerve signals.

12 Dec 2013

Dementia much higher among Native Americans and African-Americans

In the first study to look at racial and ethnic differences in dementia risk among older adults with type 2 diabetes, researchers found that dementia was much higher among Native Americans and African-Americans and lowest among Asian-Americans.

12 Dec 2013

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

Researchers use ATX-Red AR-2 as new imaging agent to illuminate tumors

Researchers discover direct evidence of genetic overlap between cognitive ability and schizophrenia

European team experts to explore role of neighborhood in everyday lives of people with dementia

New regulations could improve vets' access to care for some traumatic brain injuries

Research findings point to possible new strategy for treating ALS

New study aims to better understand brain aging and AD in adults with Down syndrome

Targacept reports top-line results from TC-5619 Phase 2b trial for negative symptoms in schizophrenia

Researchers identify first biomarker that appears to be associated with duration of delirium

Researchers receive $6M grant to determine neuropathological condition of head injuries in non-athletes

New Memorandum of Understanding signed to create partnership in neuroscience research

‘Window for intervention’ to forestall hypertensive cognitive decline

First Edition: December 16, 2013

Two UTHealth professors elected fellows of American Association for the Advancement of Science

NIH publishes new informational booklet on Lewy body dementias

Study: Brain blood vessel cells may be therapeutic targets for Alzheimer's disease

Standardized research approaches needed for developing new treatments for neurofibromatosis

Researchers uncover second rare genetic mutation linked to higher risk of Alzheimer's disease

Lund University researcher explores why type 2 diabetes raises dementia risk later in life

Blows to head may affect the brain's white matter and cognition even without concussion

Dementia much higher among Native Americans and African-Americans

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Alzheimer's & Dementia News and Research

Latest Alzheimer's & Dementia News and Research

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

Real-time Raman monitoring for pharmaceutical hot melt extrusion

Synthetic Psychedelics: A Growing Public Health Concern

How the Vutara VXL simplifies single-molecule imaging

Newsletters you may be interested in